Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03875092
What this trial is testing

Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 125
Testing effectiveness (Phase 2)Study completedNCT05309629
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827953
What this trial is testing

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nelum Corp 28
Large-scale testing (Phase 3)Looking for participantsNCT07152405
What this trial is testing

BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 490
Large-scale testing (Phase 3)UnknownNCT00442637
What this trial is testing

Maintenance Treatment Versus Observation After Induction in Advanced Colorectal Carcinoma

Who this might be right for
Colorectal Cancer Metastatic
Dutch Colorectal Cancer Group 635
Large-scale testing (Phase 3)Ended earlyNCT01279681
What this trial is testing

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Who this might be right for
Cognitive/Functional EffectsColorectal CancerNeurotoxicity
Alliance for Clinical Trials in Oncology 32
Not applicableStudy completedNCT04122430
What this trial is testing

Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours

Who this might be right for
Testicular Neoplasms
Walter and Eliza Hall Institute of Medical Research 1,135
Testing effectiveness (Phase 2)UnknownNCT04517292
What this trial is testing

Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Fudan University 160
Not applicableStudy completedNCT06190652
What this trial is testing

Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.

Who this might be right for
Metastatic Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 728
Testing effectiveness (Phase 2)Looking for participantsNCT06768307
What this trial is testing

Assessment of Adebelizumab Combined With Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageImmunotherapyChemotherapy+1 more
Peking University Cancer Hospital & Institute 60
Testing effectiveness (Phase 2)UnknownNCT02027363
What this trial is testing

Maintenance Treatment With Capecitabine in Colorectal Cancer Patients

Who this might be right for
Colorectal NeoplasmsNeoplasms Metastasis
Sun Yat-sen University 245
Testing effectiveness (Phase 2)Study completedNCT02730416
What this trial is testing

Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit 146
Testing effectiveness (Phase 2)Study completedNCT01289821
What this trial is testing

First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib

Who this might be right for
Colorectal Neoplasms
Bayer 54
Testing effectiveness (Phase 2)Study completedNCT01616849
What this trial is testing

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Stage IV Nasopharyngeal Carcinoma
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Study completedNCT02948075
What this trial is testing

Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Ovarian Cancer
NewVac LLC 31
Large-scale testing (Phase 3)Active Not RecruitingNCT06505837
What this trial is testing

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Who this might be right for
Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 395
Testing effectiveness (Phase 2)Study completedNCT02028806
What this trial is testing

MFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Yuhong Li 40
Testing effectiveness (Phase 2)UnknownNCT00980304
What this trial is testing

R Retreatment in 1st Relapsed DLBCL

Who this might be right for
Lymphomas
Shanghai Jiao Tong University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT02649829
What this trial is testing

Autologous Dendritic Cell Vaccination in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 28
Next Page